3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Breast Neoplasms
1401
Neoplasms
1128
Prostatic Neoplasms
745
Lung Neoplasms
621
Colorectal Neoplasms
599
Carcinoma, Non-Small-Cell Lung
570
Carcinoma, Hepatocellular
414
Pancreatic Neoplasms
402
Leukemia, Myeloid, Acute
398
Stomach Neoplasms
356
Multiple Myeloma
326
Brain Neoplasms
311
Ovarian Neoplasms
310
Head and Neck Neoplasms
290
Neoplasm Metastasis
275
Precursor Cell Lymphoblastic Leukemia-Lymphoma
260
Rectal Neoplasms
254
Uterine Cervical Neoplasms
248
Recurrence
248
Melanoma
243
Esophageal Neoplasms
237
Glioblastoma
232
Squamous Cell Carcinoma of Head and Neck
231
Lymphoma
214
Sarcoma
209
Urinary Bladder Neoplasms
192
Colonic Neoplasms
192
Glioma
191
Triple Negative Breast Neoplasms
188
Hematologic Neoplasms
182
Interventions
padeliporfin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
OTHER
×
Transitional Cell Cancer of Renal Pelvis and Ureter
×
Clear all
NCT04620239
2026-02-04
UCM301
Steba Biotech S.A.
Phase 3
Recruiting
100 enrolled